Tolfateb citrate tablets for rheumatoid treatment course is how long can not be generalized, the specific length of time according to the patient’s specific condition, the treatment program and other factors, there are large differences, can not give a clear time, some patients may need to take a long time. Tofacitibine citrate tablets is a new type of immunosuppressant, through the inhibition of the human body JAK enzyme to affect the cellular immune function and cell hematopoietic function of the effect of the drug is mainly used for the treatment of rheumatoid arthritis, the length of the course of treatment of patients with the use of this drug according to the specific condition of the patient, the treatment program, and other factors are different. According to the clinical trial data in the drug’s specification, tofacitib-treated patients showed greater improvement in a number of health-related aspects relative to baseline after 3 months of use, but because rheumatoid arthritis cannot be cured, some patients with the condition may need to take the drug for a long time. Common adverse reactions include infections, malignancy and lymphoid proliferation, gastrointestinal perforation and abnormal laboratory results. It is contraindicated for those who are allergic to the drug. Note that all patients should be closely monitored for signs and symptoms of developing infections during and after treatment with tofacitib. Tofacitib citrate tablets should be used under the supervision of a physician, and patients are advised to visit the rheumatology department of a regular hospital for detailed consultation.